ARMO BioSciences, Inc., a clinical-stage biotechnology company, today announced that two abstracts with clinical data on the Company's lead investigational drug AM0010 (PEGylated Interleukin-10)...

Linde LLC and IMA Life North America are inviting pharmaceutical manufacturers involved in freeze drying of delicate biotech and non-biotech derived products, such as injectable solutions,...

Novartis today announced results from a Phase III study showing Afinitor®* (everolimus), when used as an adjunctive therapy, significantly reduced treatment-resistant seizures associated with...

Today, at the Condé Nast International Luxury Conference in Seoul, MCM Chairperson & CVO Sung-Joo Kim spoke about the importance of responsibility and sustainability in business and announced a...

Mitsubishi Tanabe Pharma Corporation (President & Representative Director: Dr. Masayuki Mitsuka) has presented results from a Phase 3 study of edaravone (MCI-186) in amyotrophic lateral sclerosis...